Table 3.

Survival from first oncological treatment by contrast enhancement pattern

	Survival from First Treatment
Contrast Enhancement	Median (Years)	5 Years	10 Years	15 Years
Absence	12.7	83.2%	60.3%	44.3%
Presence	11.9	79.1%	68.5%	27.8%
Patchy and faint pattern	12.6	89.4%	72.4%	19.0%
Nodular-like pattern	4.3	47.1%	47.1%	—
Unique area	10.5	76.2%	71.4%	—
Multiple areas	9.3	71.7%	48.2%	—
Stable over time	12.3	86.3%	65.3%	40.8%
Progression over time	4.0	40.6%	19.2%	—